Skip to main content
SpringerLink
Log in

Kalzifizierende urämische Arteriolopathie (Kalziphylaxie)

Calcific uremic arteriolopathy (calciphylaxis)

  • Im Fokus
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mazhar AR, Johnson RJ, Gillen D et al (2001) Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60(1):324–332

    Article  PubMed  CAS  Google Scholar 

  2. Weenig RH, Sewell LD, Davis MD et al (2007) Calciphylaxis: natural history, risk factor analysis and outcome. J Am Acad Dermatol 56(4):569–579

    Article  PubMed  Google Scholar 

  3. Fine A, Zacharias J (2002) Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 61(6):2210–2217

    Article  PubMed  Google Scholar 

  4. Ketteler M, Biggar P, Brandenburg VM et al (2007) Epidemiologie, Pathophysiologie und Therapie der Calciphylaxie. Dtsch Arztebl 104(50):3481–3485

    Google Scholar 

  5. Coates T, Kirkland GS, Dymock RB et al (1998) Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32(3):384–391

    Article  PubMed  CAS  Google Scholar 

  6. Brandenburg V, Floege J, Ketteler M (2008) Vorstellung eines Online-Calciphylaxie-Registers des International Collaborative Calciphylaxis Network [Abstrakt]. Nieren- und Hochdruckkrankheiten 37(9):440–441

  7. Nigwekar SU, Wolf M, Sterns RH, Hix JK (2008) Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 3(4):1139–1143

    Article  PubMed  Google Scholar 

  8. Rogers NM, Teubner DJ, Coates PT (2007) Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 20(2):150–157

    Article  PubMed  Google Scholar 

  9. Raymond CB, Wazny LD (2008) Sodium thiosulfate, bisphosphonates and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm 65(15):1419–1429

    Article  PubMed  CAS  Google Scholar 

  10. Ketteler M, Brandenburg V, Jahnen-Dechent W et al (2005) Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse. Nephrol Dial Transplant 20(4):673–677

    Article  PubMed  Google Scholar 

  11. Mawad HW, Sawaya BP, Sarin R, Malluche HH (1999) Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 52(3):160–166

    PubMed  CAS  Google Scholar 

  12. Brandenburg VM, Floege J (2008) Adynamic bone disease – bone and beyond. Nephrol Dial Transplant plus 1:135–147

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Medizinische Klinik I; Kardiologie und Angiologie, Universitätsklinikum der RWTH Aachen, 52057, Aachen, Deutschland

    V.M. Brandenburg

  2. Medizinische Klinik II; Nephrologie, Universitätsklinikum der RWTH Aachen, Aachen, Deutschland

    V.M. Brandenburg & J. Floege

  3. Nephrologische Klinik, Klinikum, Coburg, Deutschland

    M. Ketteler

Authors
  1. V.M. Brandenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Floege
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Ketteler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V.M. Brandenburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandenburg, V., Floege, J. & Ketteler, M. Kalzifizierende urämische Arteriolopathie (Kalziphylaxie). Nephrologe 4, 65–66 (2009). https://doi.org/10.1007/s11560-008-0250-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-008-0250-z

Search

Navigation